Global CRO Signs TrialOne Agreement With OmniComm Systems


Applied Clinical Trials

A global CRO has signed a new agreement extending its relationship with OmniComm Systems, Inc., a provider of clinical data management technology, for another seven years. Under the terms of the agreement, the CRO will use OmniComm’s TrialOne eClinical solution in order to automate early phase studies at one of its U.S.-based clinical research units.

Read the full release here.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.